Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use ROPINIROLE extended-release tablets safely and effectively. See full prescribing information for ROPINIROLE extended-release tablets. ROPINIROLE extended-release tablets for oral use Initial U.S. Approval: 1997
Medication labelWhy this: Advisory · dailymed-prescription
Ropinirole Extended-release Tablets are indicated for the treatment of the signs and symptoms of idiopathic Parkinson’s disease.
- generic_name
- ropinirole hydrochloride
- product_names
- Ropinirole Hydrochloride
- ndc
- 55648-771, 55648-773, 55648-776, 55648-774, 55648-775, 55648-771-01, 55648-771-02, 55648-771-05, 55648-771-03, 55648-771-04, 55648-773-01, 55648-773-02, 55648-773-05, 55648-773-03, 55648-773-04, 55648-776-01, 55648-776-02, 55648-776-05, 55648-776-03, 55648-776-04, 55648-774-01, 55648-774-02, 55648-774-05, 55648-774-03, 55648-774-04, 55648-775-01, 55648-775-02, 55648-775-05, 55648-775-03, 55648-775-04
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en